-
Bank Ranking
Banks Ratios
Cement Statistics
Cement Ranking
Cement Ratios
Monetary and Economic Statistics
Oil, Gas and Fuel
Macro Economy
Consumer Spending
Inflation
Exports & Imports
Food Prices
Non Food Prices
Construction Materials
Petrochem. Ranking
Petrochem. Ratios
Retail Rankings
Retail Ratios
Grocery Ranking
Grocery Ratios
Top Growth
Dividend History
Fakeeh Care hits lowest close since debut
08/12/2025
Argaam Exclusive
AI Summary
Content Summary:
AI Summary
Content Summary: 
Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original
sources for complete details and to verify the accuracy of the information.
Shares of Tadawul-listed Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) plunged 2% today, Dec. 8, to close at the lowest level since debut on Tadawul at SAR 35.6.
The stock recorded an intraday low of SAR 35.32.
| Year High (SAR) | Year Low (SAR) |
| 72.90 | 35.32 |
| Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
| 72.90 | 35.32 |
With today's decline, the stock has lost more than 50% since the beginning of 2025.
Market Data :
| Open | 38.64 |
| Low | 38.12 |
| High | 39.00 |
| Previous Close | 38.84 |
| Change (3M) | 17.90 % |
| Change (6M) | 9.77 % |
| Market Value | 8,862.40 |
| Avg. Volume (3M) | 164,000.33 |
| Avg. Turnover (3M) | 5,822,123.40 |
| Avg. Transaction (3M) | 1,135.76 |
| Change(12M) | (0.26 %) |
| YTD | 12.02 % |
Fakeeh Care listed its shares on the Main Market (TASI) in 2024 at SAR 57.5 each, and its capital has remained unchanged since then.
Adjustments to the capital (M Riyal) :
| Date | Type | Capital (M Riyal) | Change (%) |
| 2024 | IPO | 232.00 | 16.00% |
Financial Performance :
Overview :
The company was established in 1987 in Jeddah as a sole proprietorship under the name "Dr. Soliman Abdel Kader Fakeeh Hospital Company", with capital of SAR 100 million. In 1984, they performed the first successful In-Vitro Fertilization (IVF) in the Kingdom. Shortly thereafter, they completed the first successful renal transplant at a private hospital within the Kingdom. In 1992, the company played a key role in public health by identifying the first case of Dengue Hemorrhagic Virus. ...
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Financial Ratios :
| Financial Ratio | Current |
| Market Cap (M Riyal) | 8,862.41 |
| Shares Outstanding ((M)) | 232.00 |
| Recurring EPS ( Riyal) (TTM) | 1.11 |
| Book Value (BV) ( Riyal) (Latest announcement) | 13.84 |
| Recurring P/E (TTM) | 34.57 |
| Price/book | 2.76 |
| Dividend Yield (%) (Last Year) | 0.86 |
| Return on Average Assets (%) (TTM) | 4.54 |
| Return on Average Equity (%) (TTM) | 8.23 |
| Par Value ( Riyal) | 1.00 |
| Enterprise Value (EV) (M Riyal) | 9,518.53 |
| EV/adj EBITDA | 21.15 |
| EV/Revenues | 3.06 |
Calendar :
-
04 March
General Assembly
- -
30 June
Ex-dividend Date
- -
30 June
General Assembly
-
Analyst Estimates :
45
Fair Average Price
1
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Neutral | EFG-Hermes | 42.36 | 45.00 | 6.23 % |
Call Request
Comments Analysis: